Segui
Nicolas Tsapis
Nicolas Tsapis
Université Paris-Saclay, Institut Galien Paris-Saclay, UMR CNRS 8612
Email verificata su universite-paris-saclay.fr
Titolo
Citata da
Citata da
Anno
Trojan particles: large porous carriers of nanoparticles for drug delivery
N Tsapis, D Bennett, B Jackson, DA Weitz, DA Edwards
Proceedings of the National Academy of Sciences 99 (19), 12001-12005, 2002
6222002
Onset of buckling in drying droplets of colloidal suspensions
N Tsapis, ER Dufresne, SS Sinha, CS Riera, JW Hutchinson, ...
Physical review letters 94 (1), 018302, 2005
3402005
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles
C Gómez-Gaete, N Tsapis, M Besnard, A Bochot, E Fattal
International journal of pharmaceutics 331 (2), 153-159, 2007
2972007
Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization
E Pisani, N Tsapis, J Paris, V Nicolas, L Cattel, E Fattal
Langmuir 22 (9), 4397-4402, 2006
2012006
Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells
S Mura, H Hillaireau, J Nicolas, B Le Droumaguet, C Gueutin, S Zanna, ...
International journal of nanomedicine 6, 2591, 2011
2002011
Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications
T Boissenot, A Bordat, E Fattal, N Tsapis
Journal of Controlled Release 241, 144-163, 2016
1842016
Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI
R Díaz-López, N Tsapis, E Fattal
Pharmaceutical research 27 (1), 1-16, 2010
1752010
Thermoresponsive polymer nanocarriers for biomedical applications
A Bordat, T Boissenot, J Nicolas, N Tsapis
Advanced drug delivery reviews 138, 167-192, 2019
1682019
Pickering emulsions: Preparation processes, key parameters governing their properties and potential for pharmaceutical applications
C Albert, M Beladjine, N Tsapis, E Fattal, F Agnely, N Huang
Journal of Controlled Release 309, 302-332, 2019
1582019
Pulmonary drug delivery systems for tuberculosis treatment
DD Pham, E Fattal, N Tsapis
International journal of pharmaceutics 478 (2), 517-529, 2015
1482015
Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging
E Pisani, N Tsapis, B Galaz, M Santin, R Berti, N Taulier, E Kurtisovski, ...
Advanced Functional Materials 18 (19), 2963-2971, 2008
1472008
Hyaluronic acid-coated liposomes for active targeting of gemcitabine
S Arpicco, C Lerda, E Dalla Pozza, C Costanzo, N Tsapis, B Stella, ...
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 373-380, 2013
1352013
Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells
N Grabowski, H Hillaireau, J Vergnaud, LA Santiago, S Kerdine-Romer, ...
International journal of pharmaceutics 454 (2), 686-694, 2013
1182013
Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells
S Mura, H Hillaireau, J Nicolas, S Kerdine-Römer, B Le Droumaguet, ...
Biomacromolecules 12 (11), 4136-4143, 2011
1162011
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent
R Díaz-López, N Tsapis, M Santin, SL Bridal, V Nicolas, D Jaillard, ...
Biomaterials 31 (7), 1723-1731, 2010
1162010
Sustained release of nanosized complexes of polyethylenimine and anti-TGF-β2 oligonucleotide improves the outcome of glaucoma surgery
ALG dos Santos, A Bochot, A Doyle, N Tsapis, J Siepmann, F Siepmann, ...
Journal of controlled release 112 (3), 369-381, 2006
1062006
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages
N Grabowski, H Hillaireau, J Vergnaud, N Tsapis, M Pallardy, ...
International journal of pharmaceutics 482 (1-2), 75-83, 2015
1022015
Compositions for sustained action product delivery and methods of use thereof
D Edwards, R Batycky, J Schmitke, N Tsapis, D Weitz, J Hrkach
US Patent App. 10/300,070, 2003
1022003
Dexamethasone acetate encapsulation into Trojan particles
C Gómez-Gaete, E Fattal, L Silva, M Besnard, N Tsapis
Journal of Controlled Release 128 (1), 41-49, 2008
1012008
Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor
AD Wojcicki, H Hillaireau, TL Nascimento, S Arpicco, M Taverna, S Ribes, ...
Journal of controlled release 162 (3), 545-552, 2012
1002012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20